Q3 2024 Holdings
Filed 2024-11-14 | 145 holdings | $717.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $49.4M | 500,000 | 6.9% |
| Amgen Inc(AMGN)Call | COM | 031162100 | $47.0M | 146,000 | 6.6% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $46.5M | 100,000 | 6.5% |
| Vertex Pharmaceuticals Inc(VRTX)Put | COM | 92532F100 | $46.5M | 100,000 | 6.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $33.9M | 1,030,277 | 4.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $21.8M | 426,913 | 3.0% |
| Janux Therapeutics Inc(JANX)Put | COM | 47103J105 | $16.6M | 365,200 | 2.3% |
| Biohaven LTD(BHVN)Put | COM | G1110E107 | $16.3M | 325,600 | 2.3% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $14.3M | 500,000 | 2.0% |
| Anaptysbio Inc(ANAB)Put | COM | 032724106 | $13.5M | 404,300 | 1.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $12.8M | 499,566 | 1.8% |
| Anaptysbio Inc(ANAB)Call | COM | 032724106 | $11.7M | 350,000 | 1.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $11.4M | 744,000 | 1.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.4M | 499,977 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $11.3M | 154,835 | 1.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $11.2M | 221,437 | 1.6% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $10.4M | 305,500 | 1.4% |
| Celldex Therapeutics Inc New(CLDX)Call | COM NEW | 15117B202 | $10.4M | 305,500 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.9M | 179,000 | 1.4% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $9.2M | 970,359 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.0M | 170,147 | 1.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $8.9M | 302,247 | 1.2% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $8.3M | 417,850 | 1.2% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $8.1M | 267,145 | 1.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.9M | 85,000 | 1.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.3M | 285,613 | 1.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.8M | 54,176 | 0.9% |
| Beigene LTD(ONC)Call | SPONSORED ADR | 07725L102 | $6.7M | 29,800 | 0.9% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $5.9M | 284,715 | 0.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $5.8M | 260,000 | 0.8% |
| Apellis Pharmaceuticals Inc(APLS)Put | COM | 03753U106 | $5.8M | 200,000 | 0.8% |
| Akero Therapeutics Inc(AKRO)Put | COM | 00973Y108 | $5.7M | 198,900 | 0.8% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $5.6M | 110,000 | 0.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $5.3M | 52,238 | 0.7% |
| Neumora Therapeutics Inc.(NMRA)Put | COM | 640979100 | $5.3M | 400,000 | 0.7% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $5.3M | 400,000 | 0.7% |
| Alto Neuroscience Inc(ANRO)Put | COM SHS | 02157Q109 | $5.1M | 450,000 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $5.1M | 115,200 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL)Put | COM | 558868105 | $5.0M | 23,500 | 0.7% |
| Alto Neuroscience Inc(ANRO)Call | COM SHS | 02157Q109 | $4.9M | 431,000 | 0.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $4.9M | 693,350 | 0.7% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $4.9M | 204,513 | 0.7% |
| Corbus Pharmaceuticals Hldgs(CRBP)Put | COM NEW | 21833P301 | $4.8M | 233,100 | 0.7% |
| Dyne Therapeutics Inc(DYN)Put | COM | 26818M108 | $4.8M | 133,000 | 0.7% |
| Capricor Therapeutics Inc(CAPR)Put | COM NEW | 14070B309 | $4.6M | 300,000 | 0.6% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $4.6M | 300,000 | 0.6% |
| Capricor Therapeutics Inc(CAPR)Call | COM NEW | 14070B309 | $4.6M | 300,000 | 0.6% |
| Viridian Therapeutics Inc(VRDN)Call | COM | 92790C104 | $4.6M | 200,000 | 0.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $4.5M | 544,265 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $4.3M | 150,000 | 0.6% |